{"schema_version":"secwatch.filing_event.v1","accession":"0001613103-25-000141","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2025-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.485301+00:00","generated_at":"2026-05-17T11:27:54.179520+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Medtronic Q1 revenue $8.58B (+4.8% organic); raises FY26 EPS; adds 2 directors, forms new committees","bullets":["Q1 GAAP EPS $0.81; non-GAAP EPS $1.26 (+2%), revenue $8.58B, organic growth 4.8%.","FY26 non-GAAP EPS guidance raised to $5.60-$5.66 from $5.50-$5.60; organic revenue growth ~5% reaffirmed.","Cardiac Ablation Solutions revenue +50% on pulsed field ablation strength; US +72%.","Board expanded to 13; John Groetelaars and William Jellison appointed as independent directors.","New Growth and Operations committees formed; Investor Day planned for mid-2026; engagement with Elliott Management."],"urls":{"canonical":"https://secwatch.observer/filing/0001613103-25-000141","json":"https://secwatch.observer/filing/0001613103-25-000141.json","markdown":"https://secwatch.observer/filing/0001613103-25-000141.md","text":"https://secwatch.observer/filing/0001613103-25-000141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000161310325000141/0001613103-25-000141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000161310325000141/mdt-20250818.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:27:54.179520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}